Comparing two whole-body scan methods for metastatic cancer
Part of Cancer clinical trials.
This trial tests whether a newer type of MRI scan (called whole-body DWI) can work as well as a standard PET/CT scan (called FDG PET) for finding and monitoring cancer that has spread. If you have metastatic cancer and already have a scheduled PET/CT or other scan, you may be able to get both scans done, helping researchers compare the two methods.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years of age or older.
- You have been diagnosed with cancer that has spread to other parts of the body (metastatic cancer).
- You already have a non-FDG PET imaging study scheduled within 60 days of the research scan.
- You are able to understand and sign a consent form.
- You do not have any metal implants or other reasons you cannot have an MRI scan.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two whole-body imaging scans (full-body MRI using DWI and a PET/CT scan) to see which does a better job detecting and staging active multiple myeloma. If you have been newly diagnosed or are being evaluated for suspected symptomatic myeloma, joining could help doctors learn which test is best for planning your care.
This study tests a new imaging method that combines a special PET scan (FAPI) with MRI to see if it can better find hidden invasive cancer in people with large areas of ductal carcinoma in situ (DCIS). It aims to improve surgical planning and avoid second surgeries.
This trial compares two types of PET scans to see which one better detects ER-positive breast cancer. The results could help doctors choose the best scan for tracking your cancer.
This study tests a new type of PET scan (a special imaging test) called 18F-FGIn to help doctors better detect and evaluate cancers. It may be more accurate than the standard PET scan for certain tumors like brain, liver, stomach, and colon cancers.
This trial tests whether a special PET scan (FDG PET-CT) can better track how well treatment is working for people with advanced breast cancer. It may help doctors choose the best therapy and monitor response over time.
This study looks at images from two types of scans (a PET/CT and an MRI) taken of people with stomach cancer. It aims to see how well these scans work together to show the cancer, which could guide better treatment planning.
Hear when a new Metastatic Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.